News
Alaska’s Biotech Sugar Daddy Is Showering Money on Startups
March 7, 2016 /
With a $50 billion fund willing to sit on illiquid investments for years, Alaska sees patience as a competitive advantage in making long-term bets on the drug industry.
Doni Bloomfield
MATR Supporters (view all)
Posted in: Other Economies
Sorry, we couldn't find any posts. Please try a different search.